News

Avantel Limited will hold a board meeting on Monday, October 26, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The company has closed its trading window for securities dealings from October 1, 2026, and it will remain closed until 48 hours after the financial results are declared.

Avantel Limited confirmed to the BSE Limited and the National Stock Exchange of India Limited that certificates of equity shares received for dematerialization have been duly mutilated and cancelled for the quarter ended September 30, 2026, as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. KFin Technologies Limited, the Registrar and Share Transfer Agent for Avantel Limited, certified that details of dematerialized and rematerialized securities have been furnished to the stock exchanges.

Avantel Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company`s securities will be closed from October 1, 2026, until 48 hours after the Board of Directors approves the unaudited financial results for the quarter and half year ending September 30, 2026.

Avantel Limited is proposing two corporate actions: an amendment to its Articles of Association to expand its business scope into areas including medical electronics, defense technology, artificial intelligence, and cybersecurity, and the merger of its wholly-owned subsidiary, Imeds Global Private Limited, into Avantel itself. The merger, considered a related-party transaction conducted at arm’s length, will consolidate operations and simplify governance, with no share exchange required due to Avantel’s full ownership of Imeds Global. As of March 31, 2026, Imeds Global reported revenue of Rs 160.32 crore and a net worth of Rs 2,182.83 crore, while Avantel Limited’s revenue stood at Rs 22,135.23 crore and its net worth at Rs 35,650.45 crore. The move is expected to have no impact on Avantel’s shareholding pattern.

Avantel Limited is proposing two corporate actions: an amendment to its Articles of Association to expand its business activities and the merger of its wholly-owned subsidiary, Imeds Global Private Limited, into the parent company. The amendment would allow Avantel to engage in a broader range of businesses, including medical devices, defense electronics, embedded systems, and artificial intelligence, alongside manufacturing services and digital infrastructure development. As of March 31, 2026, Imeds Global Private Limited reported revenue of Rs 160.32 crore and a net worth of Rs 2,182.83 crore, while Avantel Limited’s revenue was Rs 22,135.23 crore and its net worth was Rs 35,650.45 crore. The merger, designed to rationalize the group structure and improve operational efficiency, will not involve any share exchange and will not alter Avantel’s shareholding pattern, and is being conducted at arm’s length.